Shield Therapeutics plc carries a market capitalization of 64.71M, placing it among publicly traded companies globally.
| Market Cap | 64.71M |
| Enterprise Value | N/A |
Shield Therapeutics plc's stock has gained approximately 112.2807% over the past 52 weeks. The 50-day moving average sits at 6.60, while the 200-day moving average is 8.50.
| Beta (5Y) | N/A |
| 52-Week Price Change | 112.2807% |
| 50-Day Moving Average | 6.60 |
| 200-Day Moving Average | 8.50 |
| Average Volume (20 Days) | N/A |
Shield Therapeutics plc's most recent stock split took place on December 16, 2022 with a 1000:1029 split ratio.
| Last Split Date | 12/16/2022 |
| Split Ratio | 1000:1029 |